Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AstraZeneca’s Lynparza gets EC approval for breast cancer

pharmaceutical-technologyApril 23, 2019

Tag: AstraZeneca , Lynparza , EC , Cancer

PharmaSources Customer Service